Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data

Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data

Douglas C Wolf,1 Srihari Jaganathan,2 Chakkarin Burudpakdee,3 Arpamas Seetasith,3 Robert Low,2 Edward Lee,4 Jay Gucky,2 Mohamed Yassine,4 David A Schwartz5 1Atlanta Gastroenterology Associates, Atlanta, GA, 2UCB Pharma, Smyrna, GA, 3IQVIA, Fairfax, VA, 4UCB Pharma, Atlanta, GA, 5Inflammatory Bowel...

Full description

Bibliographic Details
Main Authors: Wolf DC, Jaganathan S, Burudpakdee C, Seetasith A, Low R, Lee E, Gucky J, Yassine M, Schwartz DA
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Patient Preference and Adherence
Subjects:
certolizumab pegol
adherence
cost
nurse assistance
patient support program
Crohn’s disease
Online Access:https://www.dovepress.com/adherence-rates-and-health-care-costs-in-crohns-disease-patients-recei-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/adherence-rates-and-health-care-costs-in-crohns-disease-patients-recei-peer-reviewed-article-PPA

Similar Items